Investorrelations.sarepta.com

Investorrelations.sarepta.com has server used 54.204.43.126 (United States) ping response time Hosted in Amazon Technologies Inc. Register Domain Names at CSC Corporate Domains, Inc.. This domain has been created 24 years, 197 days ago, remaining 168 days. You can check the 10 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server: whois.corporatedomains.com

Registrar URL: http://cscdbs.com     See All 0+

Creation Date: 1997-04-08 24 years, 197 days

Updated Date: 2021-04-05 200 days ago

Expiry Date: 2022-04-09 168 days left     See All

  Sign up for notifications near expiration

Registrar: CSC Corporate Domains, Inc.

Abuse Email: [email protected]

Abuse Phone: 8887802723

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email
www.godaddy.com2,280,668GoDaddy.com, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a PublicDomainRegistry.com[email protected]
www.whois.godaddy.com174,077GoDaddy.com, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions

Sarepta

Sarepta stock

Sarepta la

Sarepta therapeutics stock

Sarepta therapeutics cambridge

Sarepta therapeutics

Sareptah

Sarepta tx

Sarepta therapy

Sarepta 103

Sarepta 10k

Sarepta 301

Sarepta ceo

Sarepta cfo

Sarepta crl

Sarepta def

Sarepta ir

Sarepta quote

Sarepta louisiana

Sarepta therapeutics ceo

( Please select at least 2 keywords )

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Sarepta therapeutics inc latest news

› Sarepta stock news

› Sarepta therapeutics logo

› Sarepta pharma news

› Sarepta therapeutics

› Sarepta stock

› Sarepta duchenne

› Sarepta pharmaceutical

Hosting Provider

NetName: AMAZON

Organization: Amazon Technologies Inc.     See All 439,891+

Provider URL: Amazon.com

Hostname: ec2-54-204-43-126.compute-1.amazonaws.com

IP Server: 54.204.43.126 Reg: 2014-10-23, Updated: 2021-02-10

Blacklist: Check Backlist Status

Country: United States

Address: 410 Terry Ave N., Seattle, WA 98109, US

Latitude: 39.048100

Longitude: -77.472801

Name Server:

  • DNS1.EASYDNS.COM
  • DNS2.EASYDNS.NET
  • DNS3.EASYDNS.ORG
  • DNS4.EASYDNS.INFO

Abuse Email: [email protected]

Abuse Phone: +1-206-266-4064

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,706GoDaddy.com, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

No Emails Found

Find Websites hosted

1: Duchenne.com

2: Amondys45.com

3: Vyondys53.com

4: Technobezz.com Changed to: 104.26.9.27

5: Home.bt.com Changed to: 68.142.70.29

6: Whatismyip.com Changed to: 104.27.194.88

7: Clinicaltrials.sarepta.com

8: Exondys51.com

9: Limbgirdle.com

10: Sarepta.com

At least 10 Sites on this server

Port Scanner (IP: 54.204.43.126)

Investor Relations Sarepta Therapeutics, Inc.

The Investor Relations website contains information about Sarepta Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

Investorrelations.sarepta.com   DA: 29 PA: 29 MOZ Rank: 58

Contact Us Sarepta Therapeutics

  • To contact Sarepta with a question or comment, please fill in the required fields below (marked with an asterisk) and click "submit." The information you provide will be maintained in accordance with our

Sarepta.com   DA: 15 PA: 20 MOZ Rank: 36

Sarepta Therapeutics Opens Genetic Therapies Center Of

  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]
  • Sarepta’s Genetic Therapies Center of Excellence – Building Exterior; Grand Opening Ceremony (Oct 4, 2021) Photos accompanying this …

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 81

Sarepta Therapeutics Announces Pricing Of $500 Million

  • Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by applicable law
  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Media Contact: Tracy Sorrentino, 617-301-8566 tsorrentino

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 82

Sarepta Therapeutics Announces Proposed $500,000,000

  • Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof, except as required by applicable law
  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Media Contact: Tracy Sorrentino, 617-301-8566

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 83

Events & Presentations Sarepta Therapeutics, Inc.

  • Sarepta Therapeutics at the 39th Annual JPMorgan Healthcare Conference Presentation and Q&A
  • Please click the Play button below to watch the video replay of Sarepta's presentation
  • 2021.01.11 Sarepta JPMorgan 2021 presentation video_1080p from Sarepta Therapeutics on Vimeo.

Investorrelations.sarepta.com   DA: 33 PA: 21 MOZ Rank: 59

Sarepta Therapeutics Biopharmaceutical Company For Rare

  • Sarepta is engineering solutions for rare diseases with science that is on the forefront of precision genetic medicine
  • Our platforms include: gene therapy, RNA technologies, and gene editing
  • We are in a daily race to save lives stolen or impacted by rare disease
  • Patients can’t wait for the next breakthrough in medical research.

Sarepta.com   DA: 15 PA: 15 MOZ Rank: 36

$SRPT: Investors Will Love The Forecast For Sarepta

  • Sarepta Therapeutics Inc has a beta of 0.5
  • Knowing all of this, we project that Sarepta Therapeutics Inc will have a price of $123.591 in 12-months compared to its current price of $95.07
  • We can also take a look at the company’s market cap
  • Market cap is important because it allows investors to understand the relative size of one company

Wallstreetfacts.com   DA: 19 PA: 50 MOZ Rank: 76

Sarepta Therapeutics Announces Eteplirsen Demonstrates

The Investor Relations website contains information about Sarepta Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

Investorrelations.sarepta.com   DA: 29 PA: 50 MOZ Rank: 87

Hans Wigzell, MD, PhD Sarepta Therapeutics

  • Hans Wigzell, MD, PhD, has served as a member of our Board since June 2010
  • He serves as Chair of the Research and Development committee and as a member of the Nominating and Corporate Governance committee
  • Wigzell has served as a Director of Probi AB, Swedish Orphan Biovitrum AB, and Valneva SE

Sarepta.com   DA: 15 PA: 40 MOZ Rank: 64

Why Sarepta Therapeutics Fell 14.7% This Week The Motley

  • Sarepta Therapeutics ( NASDAQ:SRPT), a biotech company that specializes in genetic therapies for rare diseases, dropped 14.7% this week, according to data from S&P Global Market Intelligence

Fool.com   DA: 12 PA: 50 MOZ Rank: 72

Richard J. Barry Sarepta Therapeutics

  • Barry, a long-time stockholder of the Company, has served as a member of our Board since June 2015
  • He serves as member and Chair of the Nominating and Corporate Governance committee and as a member of the Audit committee and the Compensation committee
  • Barry has served as a director for Elcelyx Therapeutics, a pharmaceutical company, since February …

Sarepta.com   DA: 15 PA: 36 MOZ Rank: 62

Sarepta Therapeutics To Share Expression And Safety

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 79

Pipeline & Products Sarepta Therapeutics

  • At Sarepta, we are working with urgency to develop breakthrough therapies to treat genetic diseases
  • Currently, we have more than 40 investigational therapies in various stages of development—many already in late-stage clinical trials
  • In many cases, development is being accelerated by our gene therapy engine, which potentially provides a more efficient model for …

Sarepta.com   DA: 15 PA: 18 MOZ Rank: 46

News & Press Releases Sarepta Therapeutics

  • Sarepta Therapeutics Opens Genetic Therapies Center of Excellence in Columbus, Ohio
  • Sarepta Therapeutics Announces Initiation of EMBARK, a Global Pivotal Study of SRP-9001, a Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
  • Sarepta Therapeutics Announces …

Sarepta.com   DA: 15 PA: 9 MOZ Rank: 38

Why Sarepta Therapeutics Tumbled Today The Motley Fool

  • On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ:SRPT) stock fell by over 12% today
  • Investors were displeased with a company update about its

Fool.com   DA: 12 PA: 50 MOZ Rank: 77

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims

  • Such investors are advised to contact Robert S
  • Willoughby at [email protected] or 888-476-6529, ext
  • 7980.The investigation concerns whether Sarepta and certain of its officers and/or

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 83

Sarepta Embarks On Late-stage Clinical Trial Of Duchenne

Dive Brief: Sarepta Therapeutics on Monday said it has begun a Phase 3 trial of an experimental gene therapy for patients with Duchenne muscular dystrophy, marking an important milestone for the company and its partnership with Roche after several hurdles in earlier testing.; The Cambridge, Massachusetts-based biotech is competing with Pfizer to develop a …

Biopharmadive.com   DA: 21 PA: 50 MOZ Rank: 88

Should I Buy Sarepta Therapeutics Inc (SRPT)

  • Sarepta Therapeutics Inc (NASDAQ: SRPT) was in 34 hedge funds' portfolios at the end of the second quarter of 2021
  • The all time high for this statistic is 48
  • SRPT shareholders have witnessed an

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 85

Sarepta Therapeutics Announces Proposed $500,000,000

  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Investors recently got word that yet another delay is hitting Virgin Galactic, and at best

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 86

Sarepta Therapeutics Announces Initiation Of EMBARK, A

  • We encourage investors and potential investors to consult our website regularly for important information about us
  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]

Biospace.com   DA: 16 PA: 50 MOZ Rank: 86

Sarepta Therapeutics To Share Expression And Safety Results

  • The presentation will be webcast live under the investor relations section of Sarepta's website at https: [email protected]

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 92

Do Analysts Agree Wednesday On Sarepta Therapeutics Inc

  • Sarepta Therapeutics Inc (SRPT) stock has fallen -1.85% while the S&P 500 has risen 0.15% as of 1:27 PM on Wednesday, Oct 20
  • SRPT has fallen -$1.49 from the previous closing price of $80.44 on volume of 515,325 shares
  • Over the past year the S&P 500 has risen 31.46% while SRPT has fallen -42.57%.

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 97

Sarepta Therapeutics Announces Initiation Of EMBARK, A

  • The Company will host an SRP-9001 Micro-dystrophin R&D Day on Monday, Oct
  • 11, 2021, at 8:30 am Eastern Time
  • The presentation will be webcast live under the investor relations section of Sarepta

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 90

Sarepta Therapeutics To Present At Upcoming Investor

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 95

Can Sarepta's 'Remarkable' Gene Therapy Pull Shares Out Of

  • A gene therapy from Sarepta showed "remarkable" stability at two years in muscular dystrophy patients, an analyst said Friday

Investors.com   DA: 17 PA: 50 MOZ Rank: 92

Sarepta Therapeutics To Present At Upcoming Investor

  • We encourage investors and potential investors to consult our website regularly for important information about us
  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 97

Sarepta Therapeutics To Share Expression And Safety

  • We encourage investors and potential investors to consult our website regularly for important information about us
  • Source: Sarepta Therapeutics, Inc
  • Investor Contact: Ian Estepan, 617-274-4052 [email protected]
  • Media Contact: Tracy Sorrentino, 617-301-8566 [email protected]

Apnews.com   DA: 10 PA: 50 MOZ Rank: 87

Sarepta Therapeutics To Announce Second Quarter 2021

  • CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc
  • (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2021 financial

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 95

Sarepta (SRPT) Begins Pivotal Study On DMD Gene Therapy

  • SRPT announced that it has initiated a pivotal study — EMBARK — on its lead gene therapy candidate, SRP-9001, for the treatment of Duchenne muscular dystrophy

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 93

Recently Analyzed

1: Stemreturners.com 4 seconds ago

2: Bukubiruku.com 0 seconds ago

3: Volvocars.ca 2 seconds ago

4: Opencloner.com 1 seconds ago

5: Ceenyc.com 1 seconds ago

6: Vacancyingulf.com 3 seconds ago

7: Usfallenwarriors.com 2 seconds ago

8: Brewersflooring.com 5 seconds ago

9: Naturallycurly.com 1 seconds ago

10: Crazyweed.ca 2 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Crazyweed.ca4 years, 298 days leftGo Daddy Domains Canada, IncGoogle LLC
Naturallycurly.com1 year, 129 days leftGoDaddy.com, LLCAmazon Technologies Inc.
Brewersflooring.com4 years, 269 days leftRegister.com, Inc.CYBERCON, INC.
Usfallenwarriors.com 294 days leftName.com, Inc.Alibaba.com LLC
Vacancyingulf.com 207 days leftOwnRegistrar, Inc.Domain Name Services
Ceenyc.com2 years, 38 days leftGoDaddy.com, LLCGoDaddy.com, LLC
Opencloner.com 289 days leftNetwork Solutions, LLCDomain Name Services
Volvocars.ca 45 days leftCSC Corporate Domains (Canada) CompanyMicrosoft Corporation
Bukubiruku.com 301 days leftWeb Commerce Communications Limited dba WebNic.ccAmazon Technologies Inc.
Stemreturners.com 347 days leftMesh Digital LimitedDomain Name Services

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]